A vs TMO: fair value comparison
Agilent Technologies, Inc. and Thermo Fisher Scientific Inc. · Updated 2026-09-13
A currently screens as undervalued while TMO screens as fairly valued. Within Healthcare, A currently sits closer to the top of our discount ranking. A carries the stronger quality grade.
| A | TMO | |
|---|---|---|
| Verdict | Undervalued | Fairly valued |
| Last price | $146.93 | $609.82 |
| 12-month range | $114.30–$149.93 | $468.74–$600.50 |
| Sector rank | #59 of 113 Healthcare | #64 of 113 Healthcare |
| Quality grade | B | C |
| Leverage | Moderate | Moderate |
| Margin trend | Stable | Stable |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Neutral |
| DCF cross-check | — | Overvalued |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: A fair value analysis · TMO fair value analysis